Immunoexpression of galectin-3 and its potential relation to hypoxia-inducible factor-1α in ameloblastomas
Vanesa Pereira‐Prado(Universidad de la República de Uruguay), Ronell Bologna‐Molina(Universidad de la República de Uruguay), Celeste Sánchez‐Romero(Universidade Estadual de Campinas (UNICAMP)), Marco Meleti(University of Parma), Miguel Arocena(Universidad de la República de Uruguay), Rogelio González‐González(Universidad de la República de Uruguay), Gabriela Vigil-Bastitta(Universidad de la República de Uruguay), Nelly Molina‐Frechero(Universidad Autónoma Metropolitana)
Cited by 10
Related Papers
Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors
|Medicina oral, patología oral y cirugía bucal|2012|253
Extranodal NK/T cell lymphoma, nasal type: An updated overview
|Critical Reviews in Oncology/Hematology|2021|111
Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas
|Oral Oncology|2008|83
Comparative expression of syndecan‐1 and Ki‐67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma
|Pathology International|2009|62
Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review
|World Journal of Clinical Oncology|2019|58